Cargando…
Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use
Topical calcineurin inhibitors (TCI) are a relatively new class of drugs used in dermatology. There are two drug forms available – tacrolimus 0.03% or 0.1% ointment and 1.0% pimecrolimus cream. The drugs act by inhibiting synthesis of proinflammatory cytokines. The only approved indication for using...
Autores principales: | Gutfreund, Katarzyna, Bienias, Wojciech, Szewczyk, Anna, Kaszuba, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834721/ https://www.ncbi.nlm.nih.gov/pubmed/24278069 http://dx.doi.org/10.5114/pdia.2013.35619 |
Ejemplares similares
-
Multiple keloids in a 16-year-old boy with Rubinstein-Taybi syndrome
por: Bienias, Wojciech, et al.
Publicado: (2015) -
Role of primary and secondary prevention in atopic dermatitis
por: Oszukowska, Magdalena, et al.
Publicado: (2015) -
Photocarcinogenicity of selected topically applied dermatological drugs:
calcineurin inhibitors, corticosteroids, and vitamin D analogs
por: Lerche, Catharina M., et al.
Publicado: (2010) -
A 6-year-old boy with Sulzberger and Garbe dermatosis: a case report and literature review
por: Tabara, Katarzyna, et al.
Publicado: (2013) -
Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis
por: Tabara, Katarzyna, et al.
Publicado: (2015)